J Cabeza Barrera
- Occupational Therapy top 5%
- Safe Handling of Antineoplastic Drugs 6
-
- Monoclonal and Polyclonal Antibodies Research 9
- Pharmacology top 10%
-
- Protein purification and stability 13
-
- Biosimilars and Bioanalytical Methods 10
-
- Pharmaceutical studies and practices 5
-
- CAR-T cell therapy research 5
-
- Antiplatelet Therapy and Cardiovascular Diseases 4
-
- SARS-CoV-2 and COVID-19 Research 3
J Cabeza Barrera
55 papers receiving 644 citations
Peers
Comparison fields: 5 of 105
- Occupational Therapy 34
- Applied Microbiology and Biotechnology 16
- Internal Medicine 22
- Radiology, Nuclear Medicine and Imaging 132
- Pharmacology 47
Countries citing papers authored by J Cabeza Barrera
This map shows the geographic impact of J Cabeza Barrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Cabeza Barrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Cabeza Barrera more than expected).
Fields of papers citing papers by J Cabeza Barrera
This network shows the impact of papers produced by J Cabeza Barrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Cabeza Barrera. The network helps show where J Cabeza Barrera may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J Cabeza Barrera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 14 | |
| 13 | 2019 | 10 | |
| 14 | 2019 | 14 | |
| 15 | 2018 | 24 | |
| 16 | 2018 | 6 | |
| 17 | 2017 | 6 | |
| 18 | 2016 | 4 | |
| 19 | Adecuacion de las formas de dosificacion de los farmacos antiretrovirales como metodo de mejora del cumplimiento de los pacientes de VIH-SIDA | 2000 | 1 |
| 20 | INTERVENCIÓN PARA MEJORAR LA CALIDAD DE LA PRESCRIPCIÓN DE ANTIBACTERIANOS EN ATENCIÓN PRIMARIA | 1999 | 4 |
About J Cabeza Barrera
J Cabeza Barrera is a scholar working on Occupational Therapy, Family Practice and Applied Microbiology and Biotechnology, having authored 60 papers that have together received 657 indexed citations. Recurring topics across this work include Protein purification and stability (13 papers), Biosimilars and Bioanalytical Methods (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Safe Handling of Antineoplastic Drugs (6 papers), Pharmaceutical studies and practices (5 papers), CAR-T cell therapy research (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Occupational Therapy (34 citations), Applied Microbiology and Biotechnology (16 citations) and Internal Medicine (22 citations). J Cabeza Barrera has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Antonio Salmerón‐García, Natalia Navas, Cristina Lucía Dávila-Fajardo, Luis Cuadros-Rodrı́guez, Antonio Jesús Martínez-Ortega, L.F. Capitán‐Vallvey, Luis Javier Martínez-González, Rocío Morón, Manuel Colmenero and Maria Elena Rodríguez‐Cabezas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.